Status:
UNKNOWN
Assessing Health-related Quality of Life in Sarcoma Patients
Lead Sponsor:
The Netherlands Cancer Institute
Collaborating Sponsors:
Radboud University Medical Center
Leiden University Medical Center
Conditions:
Sarcoma
Eligibility:
All Genders
18+ years
Brief Summary
Although the clinical effectiveness of sarcoma treatment has improved, long-lasting and cumulative treatment side-effects may often detract from the overall marginal advantage. Information only on sur...
Detailed Description
The investigators will follow the EORTC QLG questionnaire development guidelines. First, a computerized search of the academic literature will be performed to identify all relevant HRQoL issues for an...
Eligibility Criteria
Inclusion
- Age at diagnosis 18 years or older
- Having a confirmed diagnosis of sarcoma
Exclusion
- Having any psychiatric condition or cognitive impairment that would hamper participation in interview/completion of self-reported questionnaires.
- Patients with a Gastrointestinal Stroma Tumour (GIST) diagnosis, as they are quite unique in terms of type of disease and treatment.
- Patients with Kaposi sarcoma, as this disease occurs quite often in people with AIDS
- Patients with Carcinosarcoma as this disease is generally seen as a carcinoma
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
689 Patients enrolled
Trial Details
Trial ID
NCT04071704
Start Date
May 1 2019
End Date
March 31 2023
Last Update
January 6 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Carl Gustav Carus
Dresden, Germany
2
Johannes Gutenberg University Mainz
Mainz, Germany
3
Kiing Hussein Cancer Centre
Amman, Jordan